Analyst Conference Summaries

Biotechnology Investor Aids

2seventy bio
TSVT

conference date: November 14, 2023 @ 5:00 AM Pacific Time

2seventy bio a Buy for Abecma and CAR T Platform [December 9, 2022 at Seeking Alpha]

2seventy bio Prospects [August 23, 2022 at Seeking Alpha]

2023
TSVT Q4 2022
Press Release
2seventy bio
TSVT
Q1 2023
2seventy bio
TSVT
Q2 2023
2seventy bio
TSVT
Q3 2023
March 16, 2023 May 3, 2023 Aug. 14, 2023 Nov. 14, 2023
2022
      TSVT Q3 2022
Press Release
      Nov. 7, 2022

2seventy bio (TSVT) is a biotechnology company specializing in CAR-T therapies.

2seventy bio web site


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALNY
 AMAT
 AMGN
 APRE
 ARWR
 BIIB
 BMY
 CLDX
 CDTX
 FATE
 GILD
 GLYC
 ILMN
 IMGN
 INCY
 INKT
 INO
 IONS
 MCHP
 MRNA
 PLX
 RETA
 REGN
 RNA
 SAGE
 SGEN
 SYRS
 VSTM
 VRTX
 WBA
       

Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2023 William P. Meyers